NCT02252224View on ClinicalTrials.gov

Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

CompletedOBSERVATIONAL

Enrollment

3,123

Participants

Timeline

Start Date

September 23, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Type 2 Diabetes Mellitus

Trial Locations (6)

Unknown

Research Site, Bucheon-si

Research Site, Busan

Research Site, Daejeon

Research Site, Jeonju

Research Site, Seoul

Research Site, Wŏnju

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY